Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 13,560
+200 (1.50%)
Nov 2, 2026, 3:30 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 135.68 billion as of October 30, 2026. It is the 25,146th most valuable company in the world and the 1,061st biggest in South Korea. Its market cap has decreased by 39.87% in one year.
Market Cap
135.68B
Enterprise Value
93.00B
Revenue
8.37B
Global Rank
Country Rank
#1,061 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has decreased from 291.82B to 135.68B, a decrease of -53.50%. That is a compound annual growth rate of -6.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 135.68B | -71.06% |
| Dec 30, 2025 | 468.79B | 155.02% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 244.71B |
| HLB Therapeutics | 219.91B |
| GC Genome | 215.22B |
| Bioneer | 175.77B |
| Helixmith | 170.37B |
| NeoImmuneTech | 155.82B |
| GC Cell | 151.77B |
| MedPacto | 104.54B |